Lyell Immunopharma, Inc.

NASDAQ:LYEL

Biotechnology

Healthcare
$13.67 +1.20%

+$0.15 today

Market cap
$336.08M
Beta
-0.09
P/E (TTM)
-1.1
EPS (TTM)
-$11.26
52W Low $8.46High $45.00

Volume 0.18M

Average 0.09M

Price history

Lyell Immunopharma, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-23.76%

Period high

$38.60

Period low

$7.51

Latest

$13.67

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
S-3Nov 13, 2026Nov 13, 2026
4Nov 12, 2026Nov 12, 2026
4Nov 12, 2026Nov 12, 2026
4Nov 12, 2026Nov 12, 2026
4Nov 12, 2026Nov 12, 2026
SC 13G/ANov 10, 2026Nov 10, 2026
4Nov 5, 2026Nov 5, 2026
4Nov 5, 2026Nov 5, 2026
10-QNov 4, 2026Nov 4, 2026
8-KNov 4, 2026Nov 4, 2026
8-KNov 4, 2026Nov 4, 2026
4Oct 13, 2026Oct 13, 2026
3Sep 10, 2026Sep 10, 2026
4Sep 10, 2026Sep 10, 2026
8-KSep 10, 2026Sep 10, 2026

Competitors

Who does Lyell Immunopharma, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about LYEL's filings, answered from its disclosures.

What is the latest LYEL filing?

The latest filing shown is S-3 dated Nov 13, 2026.

How many recent filings does LYEL have?

Intrinsic Alpha currently shows 20 recent filings for LYEL.